Twist Bioscience

Twist Bioscience

Yahoo Finance • 11 days ago

Twist Bioscience (TWST) Stock Could Be Reasonable On Its 9x Three Year Run

Twist Bioscience has turned into one of the market's stronger long term performers, and the latest surge leaves a simple but important question on the table. Do the company's current cash flows and their future potential really support tod... Full story

Yahoo Finance • 11 days ago

AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

Equity Insider News Commentary AUSTIN, Texas, Oct. 1, 2026 /PRNewswire/ -- Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound annual growth... Full story

Yahoo Finance • 14 days ago

Should You Buy Oracle (ORCL) Amid Project Jupiter and Negative Cash Flow Concerns?

Oracle Corporation (NYSE:ORCL) continues to insist that its massive 2.5-gigawatt AI data center campus, known as Project Jupiter, remains on schedule. However, concerns surrounding power availability, permitting, and construction have rais... Full story

Yahoo Finance • 14 days ago

Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike

Cathie Wood’s Ark Invest boosted its technology, biotechnology, and space exposure last week, led by purchases of more than 51K shares of Meta Platforms (META [https://seekingalpha.com/symbol/META]) worth $38.2M and roughly 360K shares of... Full story

Yahoo Finance • 15 days ago

Is Gemini 4 the Catalyst Alphabet (GOOGL) Needs to Win the AI Race?

Alphabet Inc. (NASDAQ:GOOGL) is approaching another important milestone in its artificial intelligence push. On September 23, Google DeepMind division head Koray Kavukcuoglu confirmed that the company is nearing the launch of Gemini 4. Th... Full story

Yahoo Finance • 20 days ago

Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership

Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem. On September 16, the company confirmed a strategic partnership... Full story

Yahoo Finance • 25 days ago

Twist Bioscience (TWST) Is Up 14.0% After Lilly AI Drug Discovery Tie-Up Is Announced - Has The Bull Case Changed?

On 16 September 2026, Twist Bioscience announced an agreement with Lilly TuneLab, under which Twist will provide antibody characterization data services using preferred Twist protocols to generate high-quality wet lab data that feed Lilly'... Full story

Yahoo Finance • 26 days ago

AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)

Parnassus Investments, an investment management company, released the "Parnassus Growth Equity Fund" second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (ne... Full story

Yahoo Finance • 26 days ago

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday

Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Se PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

Antibody characterization data generated by Twist supports TuneLab AI models designed to accelerate antibody discovery SOUTH SAN FRANCISCO, Calif., September 16, 2026--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-ca... Full story

Yahoo Finance • 27 days ago

Cathie Wood Makes Striking Switch Between AI Stock Giants

This article first appeared on GuruFocus. Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms (NASDAQ:META) while selling a nearly identical dol... Full story

Yahoo Finance • 28 days ago

Cathie Wood buys $27.9 million of surging megacap stock

Cathie Wood, head of Ark Investment Management, often buys her favorite tech stocks when she sees a new opportunity. That's what she did last week, pouring $27.9 million into Meta Platforms (META) as the company pushes deeper into AI. La... Full story

Yahoo Finance • last month

Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand

Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the "Artisan Mid Cap Fund". The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March low... Full story

Yahoo Finance • last month

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery ma... Full story

Yahoo Finance • last month

Most shorted stocks on Wall Street

[short sale] abluecup As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% of shares outst... Full story

Yahoo Finance • last month

Cathie Wood Drops $124 Million on AI Stocks, Dumps AMD

This article first appeared on GuruFocus. Cathie Wood's Ark (ARK) Invest made a sharp semiconductor rotation last week, adding roughly $53 million of Nvidia (NASDAQ:NVDA) and $41 million of Broadcom (NASDAQ:AVGO) while selling about $95 m... Full story

Yahoo Finance • last month

Cathie Wood buys $53 million of popular semiconductor stock

Cathie Wood, chief of Ark Investment Management, often uses post-earnings swings to add to her favorite tech stocks. This week, she's buying more Nvidia, adding $53 million to her stake as the stock pulled back a day after surging on bett... Full story

Yahoo Finance • last month

Cathie Wood buys $17.2 million of beaten-down AI stock

Cathie Wood is known to double down on volatile technology stocks when others start backing away. This week, she's loading up on Cerebras Systems (CBRS), the newest publicly traded AI chip company that's looking to challenge Nvidia (NVDA)... Full story

Yahoo Finance • 2 months ago

Cathie Wood sells $4 million of surging AI stock

Cathie Wood, chief of Ark Investment Management, often trims her biggest winners after sharp rallies. This week, she's selling Tempus AI (TEM), taking some shares off the table after the healthcare AI stock surged nearly 30% in days and b... Full story

Yahoo Finance • 2 months ago

Biotech Breakout: What's in focus after Moderna's cancer win?

[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [htt... Full story